Barclays lowered the firm’s price target on NOV Inc. (NOV) to $11 from $13 and keeps an Underweight rating on the shares. The company’s second half guidance of flat revenue and margins will be tough to hit considering North America activity is softening, while the tariff impact is “surprisingly low” for the largest manufacturer in the U.S., the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
